Breaking News
Investing Pro 0
💎 Reveal Undervalued Stocks Hiding in Any Market Get Started
Close

Provention Bio Inc (PRVB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Provention Bio's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
24.100 -0.110    -0.45%
31/03 - Closed. Currency in USD ( Disclaimer )
After Hours
24.110
+0.010
+0.041%
19:08:22 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 2,813,033
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 24.040 - 24.300
Provention Bio 24.100 -0.110 -0.45%

PRVB Recent Sentiments

 
This page contains information on users’ sentiments for the Provention Bio Inc stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Mar 14, 2023 zoltán csorba   23.970 -0.54%
Mar 14, 2023 Дарья Кузнецова   23.950 Mar 14, 2023 @ 23.950 0.00%
Mar 13, 2023 Melih Poyraz   24.025 Mar 16, 2023 @ 23.910 +0.48%
Mar 13, 2023 MIGUEL MIHAEL   24.000 +0.42%
Mar 13, 2023 Onur Daskin   24.000 -0.42%
Mar 13, 2023 David autista   24.150 Mar 20, 2023 @ 23.845 +1.26%
Mar 13, 2023 Besart Halili   24.150 -0.21%
Mar 13, 2023 Sam Iam   24.185 Mar 14, 2023 @ 24.100 +0.35%
Mar 13, 2023 Kewin Leszczyński   23.990 +0.46%
Mar 13, 2023 Михаил Смирнов   23.945 +0.65%
Mar 13, 2023 Giray Saliev   23.485 -2.62%
Mar 13, 2023 Tyler Philipation   23.505 -2.53%
Feb 10, 2023 Robbert Kuipers   10.310 Mar 03, 2023 @ 8.180 -20.66%
Feb 10, 2023 Robbert Kuipers   10.300 Feb 10, 2023 @ 10.310 +0.10%
Feb 10, 2023 Robbert Kuipers   10.310 Feb 10, 2023 @ 10.310 0.00%
Jan 17, 2023 Andreas Schatz   10.470 Feb 10, 2023 @ 10.400 -0.67%
Jan 03, 2023 Andres sanchez   10.490 Jan 27, 2023 @ 8.770 -16.40%
Nov 28, 2022 Gebre Selassie   9.340 Dec 05, 2022 @ 9.180 -1.71%
Nov 25, 2022 Massimo Tomasello   9.583 Dec 16, 2022 @ 9.280 -3.16%
Nov 25, 2022 José Martins   9.530 Nov 28, 2022 @ 9.550 +0.21%
Nov 22, 2022 Jose Ruiz   8.730 Dec 16, 2022 @ 9.280 +6.30%
Nov 10, 2022 Jarabe de Palo   7.578 Nov 14, 2022 @ 9.011 +18.91%
Nov 03, 2022 慎 加藤   8.660 Nov 28, 2022 @ 9.500 +9.70%
Oct 18, 2022 Burak Yurt   6.750 Nov 11, 2022 @ 8.280 +22.67%
Oct 14, 2022 Rosa F Ghozali   6.910 Nov 04, 2022 @ 7.380 -6.80%
Oct 13, 2022 Federico Lorenzo...   7.125 Nov 04, 2022 @ 7.380 +3.58%
Oct 10, 2022 Mikko Antero Ahola   7.430 Nov 04, 2022 @ 7.380 -0.67%
Oct 10, 2022 Paolo Causarano   7.270 Nov 04, 2022 @ 7.380 +1.51%
Oct 06, 2022 Rui Aleixo   6.370 Oct 28, 2022 @ 6.670 +4.71%
Oct 06, 2022 Ionut Zlate   5.985 Oct 28, 2022 @ 6.670 -11.45%
Apr 13, 2022 Zainetto Fiscale   6.576 Apr 13, 2022 @ 6.593 +0.26%
Mar 18, 2022 דורון סחר   7.720 Apr 08, 2022 @ 6.970 -9.72%
Mar 16, 2022 Jose Ruiz   7.100 Apr 08, 2022 @ 6.970 -1.83%
Feb 15, 2022 Zainetto Fiscale   6.796 Feb 21, 2022 @ 6.480 -4.65%
Feb 09, 2022 Angel Ghsjs   6.197 Mar 04, 2022 @ 5.920 -4.47%
Jan 31, 2022 Jarabe de Palo   5.380 Feb 07, 2022 @ 5.560 +3.35%
Jan 31, 2022 Robbert Kuipers   5.500 Feb 25, 2022 @ 6.520 +18.55%
Jan 31, 2022 Robbert Kuipers   5.502 Jan 31, 2022 @ 5.501 -0.02%
Jan 28, 2022 Mikko Antero Ahola   4.085 Feb 18, 2022 @ 6.480 +58.63%
Jan 28, 2022 Robbert Kuipers   4.075 Jan 31, 2022 @ 5.065 +24.29%
Jan 28, 2022 Paloma Martinez...   4.200 Feb 18, 2022 @ 6.480 +54.29%
Jan 28, 2022 Robbert Kuipers   4.148 Feb 18, 2022 @ 6.480 +56.22%
Jan 28, 2022 Robbert Kuipers   4.142 Jan 28, 2022 @ 4.145 +0.07%
Jan 03, 2022 Alex Montojo   5.950 Jan 12, 2022 @ 5.060 -14.96%
Dec 29, 2021 Bart Vanhooreweghe   5.710 Jan 21, 2022 @ 3.900 -31.70%
Dec 09, 2021 ahmad fariz   6.750 Dec 31, 2021 @ 5.620 +16.74%
Nov 22, 2021 Saleh Alsuhaibani   7.120 Nov 24, 2021 @ 7.360 +3.37%
Nov 22, 2021 Giulio Cocci   7.540 Nov 22, 2021 @ 7.420 +1.59%
Nov 16, 2021 Priyesh Mathur   6.710 Dec 10, 2021 @ 6.180 -7.90%
Nov 08, 2021 Sayabek Qanakha   7.020 Dec 03, 2021 @ 6.450 -8.12%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PRVB Comments

Write your thoughts about Provention Bio Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
zoltán csorba
zoltán csorba Mar 13, 2023 11:21PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
go 10$
John Berry
John Berry Mar 13, 2023 4:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Easy 300% winner
Mavi Yesil
Mavi Yesil Feb 13, 2023 12:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I think they will produce insulin as pills
Mavi Yesil
Mavi Yesil Feb 13, 2023 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
The convenience foods we consume make us suffer from diabetes. Diabetes is also common in children under the age of 10. Sugar is the disease of humanity. Everyone around me uses insulin. Medicines for diabetes are humanity's greatest hope. This company will do great things. drug production is great. It gives hope and expectation.
John Avenetti
John Avenetti Aug 05, 2021 1:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
earnings? they're in clinical trials.
Tim Crum
Tim Crum May 27, 2021 5:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going to pop tomorrow
John Avenetti
John Avenetti May 27, 2021 5:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it seems likely
Tim Crum
Tim Crum May 27, 2021 5:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is premarket down? doesn't make sense. I see this as likely being approved as long as the PK data with FDA gets sorted out.
Szoka Krisztian
Szoka Krisztian May 25, 2021 2:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://finance.yahoo.com/news/prvb-shareholder-alert-bronstein-gewirtz-140000371.html
Sean ONeal
Sean ONeal Mar 11, 2021 6:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
interesting info https://www.jdrf.org/blog/2020/06/15/updates-teplizumab-trial-going-believe-results/
Tom Daniel
Tom Daniel Mar 11, 2021 6:55PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
stock price doesn't GAF
Sky Emperor
SkyEmperor Dec 10, 2020 10:13AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Finally some movements
Sky Emperor
SkyEmperor Nov 19, 2020 8:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
So i expected yesterday to have some impact the presentation,now what happened anyone knows? No big changes, still in range of 15
Gene Emory
Gene Emory Nov 19, 2020 8:16AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hold till news of fda approval. I see $100 by end of 2021. Happy trading...
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email